Safety and tolerability of Evusheld in patients with CVID: The Mayo Clinic experience

BACKGROUND: The past 2 years of the COVID-19 pandemic brought with it many unknowns for patients with immunodeficiency. Because of the concern for severe infection in those with immunocompromise, patients have been eager for effective prevention, vaccination, and treatment strategies. Preexposure pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Squire, Jacqueline D., Pitlick, Mitchell M., Freeman, Catherine M., Joshi, Avni Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904854/
https://www.ncbi.nlm.nih.gov/pubmed/36777105
http://dx.doi.org/10.1016/j.jacig.2023.100081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904854/
https://www.ncbi.nlm.nih.gov/pubmed/36777105
http://dx.doi.org/10.1016/j.jacig.2023.100081

Ejemplares similares